DnB Asset Management’s Cardinal Health CAH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$12.3M Buy
51,748
+2,436
+5% +$506K 0.03% 315
2026
Q1
$10.4M Buy
49,312
+3,602
+8% +$776K 0.04% 297
2025
Q4
$9.39M Buy
45,710
+637
+1% +$120K 0.03% 317
2025
Q3
$7.07M Buy
45,073
+1,728
+4% +$267K 0.03% 356
2025
Q2
$7.28M Buy
43,345
+82
+0.2% +$12.2K 0.03% 318
2025
Q1
$5.96M Sell
43,263
-212
-0.5% -$27K 0.03% 345
2024
Q4
$5.14M Buy
43,475
+3,798
+10% +$443K 0.02% 382
2024
Q3
$4.39M Hold
39,677
0.02% 412
2024
Q2
$3.9M Buy
39,677
+3,410
+9% +$347K 0.02% 394
2024
Q1
$4.06M Sell
36,267
-44,237
-55% -$4.77M 0.02% 387
2023
Q4
$8.11M Sell
80,504
-2,017
-2% -$200K 0.04% 278
2023
Q3
$7.16M Sell
82,521
-24,187
-23% -$2.19M 0.04% 284
2023
Q2
$10.1M Sell
106,708
-30,769
-22% -$2.6M 0.06% 232
2023
Q1
$10.4M Sell
137,477
-10,787
-7% -$814K 0.07% 229
2022
Q4
$11.4M Sell
148,264
-10,604
-7% -$806K 0.08% 202
2022
Q3
$10.6M Sell
158,868
-39,951
-20% -$2.53M 0.08% 199
2022
Q2
$10.4M Buy
198,819
+7,711
+4% +$438K 0.07% 212
2022
Q1
$10.8M Buy
191,108
+42,084
+28% +$2.25M 0.06% 231
2021
Q4
$7.67M Buy
149,024
+24,609
+20% +$1.21M 0.05% 287
2021
Q3
$6.15M Sell
124,415
-2,279
-2% -$124K 0.04% 305
2021
Q2
$7.23M Buy
126,694
+65,063
+106% +$3.8M 0.05% 275
2021
Q1
$3.74M Buy
61,631
+9,023
+17% +$498K 0.03% 401
2020
Q4
$2.82M Sell
52,608
-3,755
-7% -$195K 0.02% 394
2020
Q3
$2.65M Buy
56,363
+6,579
+13% +$338K 0.03% 351
2020
Q2
$2.6M Sell
49,784
-12,796
-20% -$660K 0.03% 331
2020
Q1
$3M Sell
62,580
-5,271
-8% -$274K 0.04% 254
2019
Q4
$3.43M Buy
67,851
+7,086
+12% +$366K 0.03% 321
2019
Q3
$2.87M Buy
60,765
+2,280
+4% +$104K 0.03% 354
2019
Q2
$2.75M Sell
58,485
-4,808
-8% -$222K 0.03% 348
2019
Q1
$3.05M Buy
63,293
+25,510
+68% +$1.28M 0.03% 311
2018
Q4
$1.69M Sell
37,783
-24,500
-39% -$1.28M 0.02% 426
2018
Q3
$3.36M Sell
62,283
-20,900
-25% -$1.07M 0.04% 295
2018
Q2
$4.06M Buy
83,183
+11,600
+16% +$658K 0.05% 242
2018
Q1
$4.49M Sell
71,583
-113,500
-61% -$7.79M 0.05% 226
2017
Q4
$11.3M Buy
185,083
+150,000
+428% +$9.27M 0.14% 116
2017
Q3
$2.35M Sell
35,083
-1,000
-3% -$70.7K 0.03% 308
2017
Q2
$2.81M Sell
36,083
-1,000
-3% -$75.5K 0.04% 269
2017
Q1
$3.02M Buy
37,083
+6,100
+20% +$480K 0.05% 258
2016
Q4
$2.23M Buy
30,983
+1,600
+5% +$116K 0.04% 261
2016
Q3
$2.28M Buy
29,383
+2,600
+10% +$210K 0.04% 249
2016
Q2
$2.09M Buy
26,783
+800
+3% +$63.8K 0.04% 256
2016
Q1
$2.13M Buy
25,983
+7,500
+41% +$610K 0.04% 247
2015
Q4
$1.65M Sell
18,483
-600
-3% -$51K 0.04% 254
2015
Q3
$1.47M Buy
19,083
+100
+0.5% +$8.36K 0.04% 256
2015
Q2
$1.59M Buy
18,983
+900
+5% +$79.5K 0.04% 257
2015
Q1
$1.63M Buy
18,083
+1,200
+7% +$103K 0.04% 267
2014
Q4
$1.36M Sell
16,883
-1,300
-7% -$103K 0.03% 297
2014
Q3
$1.36M Buy
18,183
+1,700
+10% +$124K 0.03% 263
2014
Q2
$1.13M Buy
+16,483
New +$1.12M 0.02% 303
2013
Q3
Sell
-28,183
Closed -$1.33M 396
2013
Q2
$1.33M Buy
+28,183
New +$1.29M 0.04% 210

Other funds holding CAH

DnB Asset Management's CAH Position: Q2 2026 in Review

DnB Asset Management increased its Cardinal Health (CAH) stake by 4.9% in Q2 2026, buying an estimated $506K and bringing the position to 51,748 shares worth $12.3M. The position accounts for 0.03% of the portfolio, ranked #315.

DnB Asset Management first reported a position in CAH in Q2 2013 and has held it in 50 quarters since. 1,025 funds tracked by Wall St. Rank hold CAH as of Q2 2026.

  • DnB Asset Management held 51,748 shares of Cardinal Health worth $12.3M as of Q2 2026.
  • DnB Asset Management bought 2,436 Cardinal Health shares in Q2 2026, an estimated $506K.
  • Cardinal Health made up 0.03% of DnB Asset Management's portfolio in Q2 2026, its #315 holding.
  • DnB Asset Management first reported a position in Cardinal Health in Q2 2013 and has held it in 50 quarters since.
  • 1,025 funds tracked by Wall St. Rank held Cardinal Health as of Q2 2026.

Based on DnB Asset Management's 13F filing for Q2 2026, filed 11 Aug 2026.